There are errors in [Fig 3](#ppat.1008345.g001){ref-type="fig"}. The β actin loading control blot in [Fig 3C](#ppat.1008345.g001){ref-type="fig"} was in the wrong orientation in the submission. Please see the correct [Fig 3](#ppat.1008345.g001){ref-type="fig"} here.

![Effect of SIRT2 inhibition is nitric oxide mediated.\
A. Nitric oxide levels in conditioned media in response to SIRT2 inhibition at indicated time post infection. (UI- uninfected DCs, UI AK7- Uninfected DCs treated with 10 μM AK7, STM- *Salmonella* Typhimurium infected DCs, STM AK7- - *Salmonella* Typhimurium infected DCs treated with 10 μM AK7) (Data are presented as mean ± SEM of 5 independent experiments). B. qPCR analysis of NOS2 expression in DCs at indicated time post infection in response to SIRT2 inhibition. GAPDH was used as an internal control. (UI- uninfected DCs, UI AK7- Uninfected DCs treated with 10 μM AK7, STM- *Salmonella* Typhimurium infected DCs, STM AK7- *Salmonella* Typhimurium infected DCs treated with 10 μM AK7, LPS- 100 ng/ml LPS treated). (Data are presented as mean ± SEM of 3 independent experiments). C. Representative immunoblot of NOS2 in the presence and absence of SIRT2 inhibition at indicated time. (UI- uninfected DCs, UI AK7- Uninfected DCs treated with 10 μM AK7, STM- *Salmonella* Typhimurium infected DCs, STM AK7- *Salmonella* Typhimurium infected DCs treated with 10 μM AK7) D. Densitometry analysis of NOS2 level in the presence and absence of SIRT2 inhibition at indicated time. (UI- uninfected DCs, UI AK7- Uninfected DCs treated with 10 μM AK7, STM- *Salmonella* Typhimurium infected DCs, STM AK7- *Salmonella* Typhimurium infected DCs treated with 10 μM AK7) (Data are presented as mean ± SEM of 3 independent experiments). E. Percentage survival of intracellular *Salmonella* in DCs in gentamicin protection assay in the presence and absence of SIRT2 inhibitor in wild type and NOS2^-/-^ DCs. (Mock- DMSO treated, AK7- 10 μM AK7 treated). (Data are presented as mean ± SEM of 4 independent experiments) F. ^3^\[H\] Thymidine incorporation assay to assess CD8^+^ T cells proliferation during *Salmonella* infection in wild type and NOS2^-/-^ DCs in the presence and absence of SIRT2 inhibition. (Ova- Ovalbumin, DC- Dendritic cells, T cell- mixed lymphocyte, STM- *Salmonella* Typhimurium, ConA- Concanavalin A) (Data are presented as mean ± SEM of 3 independent experiments) G. IL-2 levels during CD8^+^T cells proliferation assay in response to *Salmonella* infection in wild type and NOS2^-/-^ DCs. (Ova- Ovalbumin, DC- Dendritic cells, T cell- mixed lymphocyte, STM- *Salmonella* Typhimurium) (Data are presented as mean ± SEM of 2 independent experiments) (unpaired two tailed Student's t- test, p- value, \*\*\* \< 0.0001, \*\*\<0.001, \*\<0.01).](ppat.1008345.g001){#ppat.1008345.g001}
